85 results
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
20 Dec 12
Atossa Genetics Announces Third Quarter 2012 Financial Results
12:00am
for
Breast Cancer Risk Assessment
SEATTLE, December 20, 2012 – Atossa Genetics, Inc. (NASDAQ: ATOS) today announced financial results for the third quarter … and marketed product, the ForeCYTE Breast Health Test for breast cancer risk assessment,” stated Steven C. Quay, M.D., Ph.D., Chairman, President and CEO
S-1
uk0ec utns
30 Mar 10
IPO registration
12:00am
8-K
vg2b2rs eo8
17 May 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.2
2qh3a 00ns7d5qed3ch
13 Sep 18
Atossa Genetics Announces Preliminary Results from
12:00am
8-K
EX-99.1
kyr 2fowbbgb2z4
13 Nov 20
Atossa Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
9:30am
424B2
bz5c o630rj6rx
4 Feb 21
Prospectus for primary offering
4:16pm
CORRESP
q0o ih84569f2dulghb
19 Oct 12
Correspondence with SEC
12:00am